Cargando…

Clozapine-Induced Microseizures, Orofacial Dyskinesia, and Speech Dysfluency in an Adolescent with Treatment Resistant Early Onset Schizophrenia on Concurrent Lithium Therapy

Clozapine is an atypical antipsychotic used in the treatment of refractory schizophrenia. It has a well-known side effect profile, including agranulocytosis, decreased seizure threshold, and tardive dyskinesia. In addition, numerous case reports have described clozapine-induced stuttering in adults....

Descripción completa

Detalles Bibliográficos
Autores principales:	Rachamallu, Vivekananda, Haq, Ayman, Song, Michael M., Aligeti, Manish
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556608/ https://www.ncbi.nlm.nih.gov/pubmed/28835863 http://dx.doi.org/10.1155/2017/7359095

Ejemplares similares

Concomitant Use of Topiramate Inducing Neutropenia in a Schizophrenic Male Stabilized on Clozapine
por: Sharma, Pravesh, et al.
Publicado: (2016)

Levetiracetam-induced transaminitis in a young male with traumatic brain injury
por: Rachamallu, Vivekananda, et al.
Publicado: (2017)

Tardive dyskinesia with clozapine dose reduction or withdrawal dyskinesia?
por: Praharaj, Samir Kumar
Publicado: (2011)

Clozapine-induced Tardive Dyskinesia
por: Das, Soumitra, et al.
Publicado: (2017)

Intraoperative microseizure detection using a high-density micro-electrocorticography electrode array
por: Sun, James, et al.
Publicado: (2022)

Altered patterns of directed connectivity within the reading network of dyslexic children and their relation to reading dysfluency
por: Žarić, Gojko, et al.
Publicado: (2016)

Orofacial Dyskinesia in Uremia in Polycystic Kidney Disease
por: Arora, Nidhi, et al.
Publicado: (2023)

Orofacial dyskinesia post resection of pineal gland tumor
por: Yazbeck, Mohamad, et al.
Publicado: (2020)

Relapse of tardive dyskinesia due to reduction in clozapine dose
por: Shrivastava, Meena, et al.
Publicado: (2009)

Reversal of reserpine-induced orofacial dyskinesia and catalepsy by Nardostachys jatamansi
por: Patil, Rupali A., et al.
Publicado: (2012)

PM493. Interactions of tardive dyskinesia with cognitive function in patients with schizophrenia: worsening of working memory with clozapine treatment
por: Kim, Soo In, et al.
Publicado: (2016)

Speech and orofacial apraxias in Alzheimer's disease
por: Cera, Maysa Luchesi, et al.
Publicado: (2013)

Protective Effect of Leaves of Murraya koenigii on Reserpine-Induced Orofacial Dyskinesia
por: Patil, Rupali, et al.
Publicado: (2012)

Crocin prevents haloperidol-induced orofacial dyskinesia: possible an antioxidant mechanism
por: Kamyar, Marzyeh, et al.
Publicado: (2016)

Speech and orofacial apraxias in Alzheimer's disease – CORRIGENDUM
por: Cera, Maysa Luchesi, et al.
Publicado: (2013)

Orofacial Praxis Abilities in Children with Speech Disorders
por: Bertagnolli, Ana Paula Coitino, et al.
Publicado: (2015)

Orofacial Dyskinesia and Intractable Hiccups in a Patient with Varicella-zoster Virus Encephalomyelitis
por: Funatsu, Akito, et al.
Publicado: (2022)

Acute-onset Orofacial Dyskinesia with a Single Low Dose of Oral Flupentixol: A Case Report
por: Gupta, Prashant, et al.
Publicado: (2018)

Tardive Dyskinesia After Aripiprazole Treatment That Improved With Tetrabenazine, Clozapine, and Botulinum Toxin
por: Aguilar, Lourdes, et al.
Publicado: (2019)

A Case Report of Baclofen- and Clozapine-Induced Dyskinesia: A Movement Disorder
por: Maliha, Maisha, et al.
Publicado: (2022)

USE OF CLOZAPINE IN CHILDHOOD SCHIZOPHRENIA
por: Srinivasan, T.N., et al.
Publicado: (1997)

A Study on Drug-Induced Tardive Dyskinesia: Orofacial Musculature Involvement and Patient’s Awareness
por: Anusa, Arunachalam M., et al.
Publicado: (2019)

Olanzapine-induced Concurrent Tardive Dystonia and Tardive Dyskinesia in Schizophrenia with Intellectual Disability: A Case Report
por: Choe, Young Min, et al.
Publicado: (2020)

Concurrent autoimmune orofacial lesions: A rare occurrence!
por: Nayak, Apurva, et al.
Publicado: (2022)

PM412. Emergence of Tardive Dyskinesia upon Clozapine Treatment: A Case Report
por: Moon, Sun-Young, et al.
Publicado: (2016)

Slower clozapine titration is associated with delayed onset of clozapine-induced fever among Japanese patients with schizophrenia
por: Kikuchi, Yuki, et al.
Publicado: (2023)

Effectiveness of clozapine in treatment-resistant schizophrenia
por: Raguraman, Janakiraman, et al.
Publicado: (2005)

Clozapine: Improvement of Negative Symptoms of Schizophrenia
por: Khan, Afaque H, et al.
Publicado: (2017)

Clozapine Response in Schizophrenia and Hematological Changes
por: Blackman, Graham, et al.
Publicado: (2021)

Clozapine discontinuation withdrawal symptoms in schizophrenia
por: Blackman, Graham, et al.
Publicado: (2021)

Management of patients with Clozapine Resistant Schizophrenia
por: Rajendran*, Nithya Ragavi, et al.
Publicado: (2022)

Association between clinical factors and orofacial dyskinesias in anti‐N‐methyl‐D‐aspartate receptor encephalitis
por: Hang, Hailun, et al.
Publicado: (2022)

Difference between treatment-resistant schizophrenia and clozapine-resistant schizophrenia
por: Tseng, Ping-Tao, et al.
Publicado: (2022)

Clozapine- and non-clozapine-associated neutropenia in patients with schizophrenia: a retrospective cohort study
por: Johannsen, Claas-Frederik, et al.
Publicado: (2022)

Clozapine Reverses Dysfunction of Glutamatergic Neurons Derived From Clozapine-Responsive Schizophrenia Patients
por: Hribkova, Hana, et al.
Publicado: (2022)

Use of lithium in clozapine-induced neutropenia: a case report
por: Suraweera, Chathurie, et al.
Publicado: (2014)

Repetitive Exposure to Orofacial Somatosensory Inputs in Speech Perceptual Training Modulates Vowel Categorization in Speech Perception
por: Ito, Takayuki, et al.
Publicado: (2022)

A False Case of Clozapine-Resistant Schizophrenia
por: Maia-de-Oliveira, J. P., et al.
Publicado: (2010)

REFRACTORY SCHIZOPHRENIA, CLOZAPINE AND EPILEPSY : MANAGEMENT STRATEGIES
por: Guha, Prathama, et al.
Publicado: (1998)

AN OPEN STUDY OF CLOZAPINE IN THE TREATMENT OF RESISTANT SCHIZOPHRENIA
por: Desai, Neena, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_9e9o7gbujn4v4lk6qk94pgvj0v